Related Experiment Video
Updated: Jun 23, 2026
Detection of MicroRNAs in Microglia by Real-time PCR in Normal CNS and During Neuroinflammation
Published on: July 23, 2012
Response of miRNA to treatment with Hypericum perforatum L. oil in multiple sclerosis
Huri Dedeakayogullari1, Zozan Guleken2, Sahabettin Selek3
1Medical Biochemistry Department, Faculty of Medicine, Biruni University, Istanbul, Türkiye; Biruni University Research Center (B@MER), Biruni University, Istanbul, Türkiye.
Abstract:
MicroRNA‑regulated gene expression plays an important role in autoimmune diseases, such as multiple sclerosis (MS). This study investigated the expression patterns of microRNAs (miRNAs) in MS in brain tissues using an animal experimental autoimmune encephalomyelitis (EAE) model treated with Hypericum perforatum (HP) oil. C57BL/6 J mice were divided into two groups: MS and control. The MS group was subdivided into sham (MS) and MS+HP. After the EAE induction treatment protocol, the patterns of miRNA expression profiles were determined in brain samples of the groups. The array data identified eleven miRNAs and candidate miRNA validation was performed by RT‑qPCR. A literature review of the validated miRNAs found that six of the eleven miRNAs (miR‑200a‑3p, miR‑200b‑3p, miR‑200c‑3p, miR‑182‑5p, miR‑183‑5p, and miR‑1298‑5p) were directly associated with MS. These miRNAs have been suggested as biomarkers of MS because they are highly correlated with the pathology of the disease. Furthermore, miRNA array analysis identified five candidate miRNAs (miR‑299a‑5p, miR‑206‑3p, miR‑325‑5p, miR‑10b‑5p, miR‑429‑3p) that are highly likely to be associated with MS pathogenesis, which could be helpful in the diagnosis and treatment of MS disease. This research offers vital insights that could be utilized in creating biomarkers and advancing treatments for MS.
Insights
MicroRNA expression is crucial in multiple sclerosis (MS). This study identified specific microRNAs (miRNAs) in an MS mouse model, suggesting potential biomarkers for diagnosis and treatment.
Area of Science:
- Neuroimmunology
- Molecular Biology
Background:
- MicroRNA-regulated gene expression is implicated in autoimmune diseases like multiple sclerosis (MS).
- Understanding miRNA profiles in MS pathogenesis is vital for developing new therapeutic strategies.
Purpose of the Study:
- To investigate microRNA (miRNA) expression patterns in the brain tissues of a mouse model of multiple sclerosis (MS).
- To identify potential miRNA biomarkers for MS diagnosis and treatment using an experimental autoimmune encephalomyelitis (EAE) model.
Main Methods:
- Utilized an experimental autoimmune encephalomyelitis (EAE) mouse model, with groups including control, MS, and MS treated with Hypericum perforatum (HP) oil.
- Performed miRNA expression profiling using array analysis on brain samples.
- Validated candidate miRNAs using RT-qPCR and conducted a literature review to assess their association with MS.
Main Results:
- Eleven miRNAs were identified through array analysis.
- Six validated miRNAs (miR-200a-3p, miR-200b-3p, miR-200c-3p, miR-182-5p, miR-183-5p, miR-1298-5p) showed direct association with MS pathology.
- Five additional candidate miRNAs (miR-299a-5p, miR-206-3p, miR-325-5p, miR-10b-5p, miR-429-3p) were identified as potentially associated with MS pathogenesis.
Conclusions:
- Specific miRNAs are significantly correlated with MS pathology and can serve as potential biomarkers.
- The identified miRNAs offer insights for advancing the diagnosis and treatment of multiple sclerosis.
- This study highlights the role of miRNA dysregulation in MS and suggests novel therapeutic targets.
More Related Videos
10:37Perturbations of Circulating miRNAs in Irritable Bowel Syndrome Detected Using a Multiplexed High-throughput Gene Expression Platform
Published on: November 30, 2016
05:44Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice
Published on: October 13, 2023
